ABCB1 and lymphoma: In canine lymphoma, mutations in the ABCB1 gene may not only increase drug efflux but also impact the expression and conformation of intracellular drug targets, contributing to reduced sensitivity to chemotherapeutics like vincristine and doxorubicin [85].